Matinas BioPharma to Present at the 2nd Annual Dawson James Securities Growth Stock Conference
Oct 13, 2016 11:05 am UTC| Business
BEDMINSTER, N.J., Oct. 13, 2016 -- Matinas BioPharma Holdings, Inc. (OTCQB:MTNB), a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective broad spectrum therapeutics for the...
Oct 13, 2016 11:02 am UTC| Business
Dublin, Oct. 13, 2016 -- Research and Markets has announced the addition of the "Global Smart Lighting Market Analysis Trends - Industry Forecast to 2025" report to their offering. ...
Onconova Therapeutics, Inc. to Present Corporate Update at 2016 BIO Investor Forum
Oct 13, 2016 11:01 am UTC| Business
NEWTOWN, Pa., Oct. 13, 2016 -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that...
Oct 13, 2016 11:01 am UTC| Business
FDA agrees that Overall Response Rate (ORR) data from revised GENUINE study can be used to request pre-BLA (Biologics License Application) meeting If results of the revised GENUINE study are positive, the Company plans...
FDA, CLINUVEL to Discuss SCENESSE® at Pre-NDA Meeting
Oct 13, 2016 11:01 am UTC| Business
MELBOURNE, Australia and NEW YORK, Oct. 13, 2016 -- CLINUVEL PHARMACEUTICALS LTD (ASX:CUV) (OTC:CLVLY) (XETRA:UR9)today announced that it will meet with the US Food and Drug Administration (FDA) on 7 November to...
Pluristem CEO Zami Aberman Re-Elected to Alliance for Regenerative Medicine’s Board of Directors
Oct 13, 2016 11:01 am UTC| Business
HAIFA, Israel, Oct. 13, 2016 -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today announced its Chairman and CEO, Zami Aberman, has been re-elected...
Aptose Provides Update on FDA Clinical Hold of APTO-253
Oct 13, 2016 11:01 am UTC| Business
SAN DIEGO and TORONTO, Oct. 13, 2016 -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer,...